MC2262A1 - Composes antibacteriens - Google Patents

Composes antibacteriens

Info

Publication number
MC2262A1
MC2262A1 MC932182A MC2182A MC2262A1 MC 2262 A1 MC2262 A1 MC 2262A1 MC 932182 A MC932182 A MC 932182A MC 2182 A MC2182 A MC 2182A MC 2262 A1 MC2262 A1 MC 2262A1
Authority
MC
Monaco
Prior art keywords
antibacterial compounds
antibacterial
compounds
Prior art date
Application number
MC932182A
Other languages
English (en)
French (fr)
Inventor
Louis Dax Scott
Dalton Keith Dennis
Loreen Rossman Pamela
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC2262A1 publication Critical patent/MC2262A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/26—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 4
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MC932182A 1990-04-09 1991-04-05 Composes antibacteriens MC2262A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50613590A 1990-04-09 1990-04-09

Publications (1)

Publication Number Publication Date
MC2262A1 true MC2262A1 (fr) 1993-04-26

Family

ID=24013339

Family Applications (1)

Application Number Title Priority Date Filing Date
MC932182A MC2262A1 (fr) 1990-04-09 1991-04-05 Composes antibacteriens

Country Status (17)

Country Link
EP (1) EP0451764A1 (no)
JP (1) JPH04234884A (no)
AU (1) AU7420591A (no)
BR (1) BR9101418A (no)
CA (1) CA2039987A1 (no)
CS (1) CS94391A2 (no)
FI (1) FI911666A (no)
HU (1) HUT57769A (no)
IE (1) IE911161A1 (no)
IL (1) IL97797A0 (no)
MC (1) MC2262A1 (no)
MX (1) MX25231A (no)
NO (1) NO911357L (no)
PT (1) PT97287A (no)
TW (1) TW216420B (no)
YU (1) YU62991A (no)
ZA (1) ZA912279B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0366189A3 (en) * 1988-10-24 1992-01-02 Norwich Eaton Pharmaceuticals, Inc. Novel antimicrobial lactam-quinolones
US5180719A (en) * 1988-10-24 1993-01-19 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl lactam esters
US5328908A (en) * 1988-10-24 1994-07-12 Procter & Gamble Pharmaceuticals, Inc. Antimicrobial quinolone thioureas
US5491139A (en) * 1988-10-24 1996-02-13 The Procter & Gamble Company Antimicrobial quinolonyl lactams
US5273973A (en) * 1988-10-24 1993-12-28 Norwich Eaton Pharmaceuticals, Inc. Antimicrobial quinolonyl esters
CA2001203C (en) * 1988-10-24 2001-02-13 Thomas P. Demuth, Jr. Novel antimicrobial dithiocarbamoyl quinolones
ATE193890T1 (de) * 1990-04-18 2000-06-15 Procter & Gamble Pharma Antimikrobielle chinolonyl-lactame
EP0606336B1 (en) * 1991-10-01 1997-03-19 PROCTER & GAMBLE PHARMACEUTICALS, INC. Process for making antimicrobial quinolonyl lactams
DE4234078A1 (de) * 1992-10-09 1994-04-14 Bayer Ag Chinoloncarbonsäuren
DE4234330A1 (de) * 1992-10-12 1994-04-14 Bayer Ag Chinoloncarbonsäuren
WO1996004247A1 (en) * 1994-08-02 1996-02-15 The Procter & Gamble Company Process for making antimicrobial compounds
WO1996004286A1 (en) * 1994-08-02 1996-02-15 The Procter & Gamble Company Process for making quinolonyl lactam antimicrobials and novel intermediate compounds
EP0695753A1 (en) * 1994-08-05 1996-02-07 Zeneca Limited Carbapenem derivatives containing a bicyclic substituent, process for their preparation, and their use
US5607928A (en) * 1994-08-05 1997-03-04 Zeneca Limited Carbapenem derivatives containing a bicyclic ketone substituent and their use as anti-infectives
US5973142A (en) * 1997-01-21 1999-10-26 Yasuda; Nobuyoshi Process for synthesizing carbapenem intermediates
JP2001519773A (ja) * 1997-01-21 2001-10-23 メルク エンド カンパニー インコーポレーテッド カルバペネム中間体の合成プロセス
US6080854A (en) * 1997-08-25 2000-06-27 Merck & Co., Inc. Process for synthesizing carbapenem intermediates

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1179675A (en) * 1981-01-30 1984-12-18 Erwin Gotschi 7-oxo-1-azabicyclo ¬3,2,0| heptene-2-derivatives
US4680292A (en) * 1984-12-13 1987-07-14 Merck & Co., Inc. Carbapenems and 1-methylcarbapenems having a 2-heteroaryliumaliphatic substituent
US4767762A (en) * 1985-12-23 1988-08-30 Abbott Laboratories Tricyclic quinoline and naphthyride antibacterials
EP0366189A3 (en) * 1988-10-24 1992-01-02 Norwich Eaton Pharmaceuticals, Inc. Novel antimicrobial lactam-quinolones
ATE194353T1 (de) * 1988-10-24 2000-07-15 Norwich Eaton Pharma Antimikrobielle quinolonyllactamester
EP0366193A3 (en) * 1988-10-24 1992-01-08 Norwich Eaton Pharmaceuticals, Inc. Novel antimicrobial quinolonyl lactams

Also Published As

Publication number Publication date
NO911357D0 (no) 1991-04-08
PT97287A (pt) 1992-01-31
CS94391A2 (en) 1991-11-12
ZA912279B (en) 1992-02-26
IL97797A0 (en) 1992-06-21
FI911666A (fi) 1991-10-10
AU7420591A (en) 1991-10-10
CA2039987A1 (en) 1991-10-10
HU911132D0 (en) 1991-10-28
NO911357L (no) 1991-10-10
MX25231A (es) 1993-10-01
YU62991A (sh) 1994-04-05
IE911161A1 (en) 1991-10-09
HUT57769A (en) 1991-12-30
FI911666A0 (fi) 1991-04-08
BR9101418A (pt) 1991-11-26
EP0451764A1 (en) 1991-10-16
TW216420B (no) 1993-11-21
JPH04234884A (ja) 1992-08-24

Similar Documents

Publication Publication Date Title
NO923033D0 (no) Antimikrobielle blandinger
BR1100956A (pt) Composto
NO924000D0 (no) Antimikrobielle kinolontiourea-forbindelser
MX9100513A (es) Compuestos
FI930165A (fi) Framstaellning av synnerligen aktiva tvaettmedelspartiklar
DK0516650T3 (da) Skårlægger
MX9100018A (es) Histidinas sustituidas
NO920103L (no) Antibakterielle midler
MC2262A1 (fr) Composes antibacteriens
MX9100517A (es) Compuestos
FI923800A (fi) Syntetiska polypeptider
FI925805A0 (fi) Framstaellning av kompositmaterial
FI925609A (fi) Foerfarande foer framstaellning av sykliska sulfater
FI930034A (fi) Foerfarande foer framstaellning av avlaongt foeremaol
FI925544A0 (fi) Bensoesyraderivat foer behandling av leukotrienassocierade sjukdomar
BR9005812A (pt) Poliimidossiloxanos cristalinos
DK106991A (da) Dichloranilinforbindelser
KR920005705U (ko) 낚시찌
FI925546A (fi) Amidkopplade pyridylbensoesyraderivat foer behandling av leukotrien-associerade sjukdomar
FI930013A (fi) Hormonderivat av bakre hypofysloben
BR9107233A (pt) Carreta de engate puxada por cavalos
KR920000060U (ko) 낚시찌
FI924154A (fi) Foerfarande foer framstaellning av penem-estrar
FI923795A (fi) Kretselement foer aostadkommande av en spaerrspaenning foer kopplinsdioder
IT9020674A1 (it) Composti ammelinici